Inhibikase receives arbitration demand for $1.625M from Pivot over milestone payments

Inhibikase Therapeutics, Inc.

Pivot Holding LLC, successor to Sphaera Pharma, demands $1.625 million plus interest for alleged breach of 2012 collaboration agreement.
Company believes claims are without merit and will vigorously dispute; intends to assert counterclaims.
Arbitration proceeding administrated by American Arbitration Association; no timeline for resolution disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.